Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 2739041)

Published in Virology on March 18, 2008

Authors

Ilker K Sariyer1, Kamel Khalili, Mahmut Safak

Author Affiliations

1: Department of Neuroscience and Center for Neurovirology, Laboratory of Molecular Neurovirology, Temple University School of Medicine, Philadelphia, PA 19122, USA.

Articles citing this

Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (2012) 2.92

Regulation of gene expression in primate polyomaviruses. J Virol (2009) 1.61

JC virus: an oncogenic virus in animals and humans? Semin Cancer Biol (2009) 1.28

JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant. PLoS One (2012) 1.07

Regulation of human neurotropic JC virus replication by alternative splicing factor SF2/ASF in glial cells. PLoS One (2011) 0.99

JC virus mediates invasion and migration in colorectal metastasis. PLoS One (2009) 0.97

Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content. Virol J (2011) 0.97

Chromatin at the intersection of viral infection and DNA damage. Biochim Biophys Acta (2009) 0.97

JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication. Virology (2012) 0.89

IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression. PLoS One (2015) 0.89

Agnogene deletion in a novel pathogenic JC virus isolate impairs VP1 expression and virion production. PLoS One (2013) 0.87

Essential roles of Leu/Ile/Phe-rich domain of JC virus agnoprotein in dimer/oligomer formation, protein stability and splicing of viral transcripts. Virology (2013) 0.86

JC virus-induced Progressive Multifocal Leukoencephalopathy. Future Virol (2010) 0.86

Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: implications for their roles in agnoprotein function. Virology (2011) 0.85

JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity. PLoS One (2010) 0.81

Generation and characterization of JCV permissive hybrid cell lines. J Virol Methods (2009) 0.81

JC virus nucleotides 376-396 are critical for VP1 capsid protein expression. J Neurovirol (2014) 0.78

Emerging Roles of Viroporins Encoded by DNA Viruses: Novel Targets for Antivirals? Viruses (2015) 0.78

Nuclear magnetic resonance structure revealed that the human polyomavirus JC virus agnoprotein contains an α-helix encompassing the Leu/Ile/Phe-rich domain. J Virol (2014) 0.77

Review on the role of the human Polyomavirus JC in the development of tumors. Infect Agent Cancer (2017) 0.75

Emerging From the Unknown: Structural and Functional Features of Agnoprotein of Polyomaviruses. J Cell Physiol (2016) 0.75

Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release. J Cell Physiol (2017) 0.75

Articles cited by this

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30

Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91

Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J (2001) 9.40

Construction and analysis of viable deletion mutants of simian virus 40. J Virol (1976) 9.11

Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell (1990) 6.12

Human polyomavirus JC virus genome. J Virol (1984) 5.87

Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol (2007) 5.24

Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol (2002) 4.77

CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer (2007) 3.46

Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell (2003) 3.33

The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell (1993) 3.27

Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci U S A (1985) 2.93

Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin Cancer Biol (2001) 2.85

Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol Cell Biol (1991) 2.80

The replication functions of SV40 T antigen are regulated by phosphorylation. Cell (1990) 2.51

Involvement of PP2A in viral and cellular transformation. Oncogene (2005) 2.07

Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol Cell Biol (1991) 1.99

Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription. J Virol (1993) 1.98

Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirol (1995) 1.85

Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. EMBO J (1989) 1.83

Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells. Mol Cell Biol (1997) 1.79

Regulation of innate immune response by MAP kinase phosphatase-1. Cell Signal (2007) 1.65

Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha. Science (1997) 1.58

A rapid in vitro polyomavirus DNA replication assay. J Virol Methods (2004) 1.57

Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation. EMBO J (1997) 1.57

Adenovirus type 5 E4 open reading frame 4 protein induces apoptosis in transformed cells. J Virol (1998) 1.54

Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice. Proc Natl Acad Sci U S A (1986) 1.43

Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation. J Virol (1994) 1.42

Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. N Engl J Med (1982) 1.41

Protein serine/threonine phosphatases: life, death, and sleeping. Curr Opin Cell Biol (2005) 1.41

Different oligomeric forms of protein phosphatase 2A activate and inhibit simian virus 40 DNA replication. Mol Cell Biol (1994) 1.40

Requirement for the simian virus 40 small tumor antigen in tumorigenesis in transgenic mice. Mol Cell Biol (1988) 1.40

Identification of critical elements within the JC virus DNA replication origin. J Virol (1990) 1.36

A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays. J Virol (1996) 1.36

The role of the SV40 ST antigen in cell growth promotion and transformation. Semin Cancer Biol (2001) 1.33

Structural basis of PP2A inhibition by small t antigen. PLoS Biol (2007) 1.32

Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. J Neurovirol (1995) 1.31

Mechanism of activation of simian virus 40 DNA replication by protein phosphatase 2A. Mol Cell Biol (1992) 1.27

Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology (1995) 1.27

Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene (1999) 1.23

Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A. J Virol (1996) 1.22

Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J Virol (2001) 1.20

Protein phosphatase 2A dephosphorylates simian virus 40 large T antigen specifically at residues involved in regulation of DNA-binding activity. J Virol (1991) 1.19

Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene (2002) 1.19

Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol (2002) 1.17

Replication activity of JC virus large T antigen phosphorylation and zinc finger domain mutants. J Neurovirol (1996) 1.16

Variable defectiveness for lytic growth of the dl 54/59 mutants of simian virus 40. J Virol (1980) 1.15

Factors contributing to the restricted DNA replicating activity of JC virus. Virology (1991) 1.15

Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins. Virology (1989) 1.14

PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum. J Biol Chem (2006) 1.13

Reciprocal interaction between two cellular proteins, Puralpha and YB-1, modulates transcriptional activity of JCVCY in glial cells. Mol Cell Biol (1999) 1.13

Simian virus 40 small t antigen mediates conformation-dependent transfer of protein phosphatase 2A onto the androgen receptor. Mol Cell Biol (2005) 1.13

Mutational analysis of simian virus 40 small-t antigen. J Virol (1990) 1.13

Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling. Mol Cell Biol (2002) 1.12

Evidence for a shift in 5'-termini of early viral RNA during the lytic cycle of JC virus. Virology (1987) 1.12

Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J Virol (2006) 1.12

T-antigen kinase inhibits simian virus 40 DNA replication by phosphorylation of intact T antigen on serines 120 and 123. J Virol (1994) 1.12

Identification of FEZ1 as a protein that interacts with JC virus agnoprotein and microtubules: role of agnoprotein-induced dissociation of FEZ1 from microtubules in viral propagation. J Biol Chem (2005) 1.11

Dissociation of heterochromatin protein 1 from lamin B receptor induced by human polyomavirus agnoprotein: role in nuclear egress of viral particles. EMBO Rep (2005) 1.10

Characterization of the Aalpha and Abeta subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolution. Biochem J (2003) 1.09

Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology (2006) 1.09

Control of simian virus 40 DNA replication by the HeLa cell nuclear kinase casein kinase I. Mol Cell Biol (1993) 1.09

Induction of peripheral neuroblastomas in Syrian hamsters after injection as neonates with JC virus, a human polyoma virus. Cancer Res (1978) 1.02

The simian virus 40 small-t and large-T antigens jointly regulate cell cycle reentry in human fibroblasts. J Virol (1999) 1.00

Identification of structural elements involved in the interaction of simian virus 40 small tumor antigen with protein phosphatase 2A. J Biol Chem (1998) 1.00

Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J Virol (1999) 1.00

Simian virus 40 small-t antigen stimulates viral DNA replication in permissive monkey cells. J Virol (1994) 0.99

Protein phosphatase 1 regulates the stability of the circadian protein PER2. Biochem J (2006) 0.99

Transforming activities of JC virus early proteins. Adv Exp Med Biol (2006) 0.98

Cell cycle progression in monkey cells expressing simian virus 40 small t antigen from adenovirus vectors. J Virol (1998) 0.98

Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J Virol (2003) 0.98

Structure and function of JC virus T' proteins. J Neurovirol (2001) 0.97

Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen. J Virol (2003) 0.96

Simian virus 40 small tumor antigen induces deregulation of the actin cytoskeleton and tight junctions in kidney epithelial cells. J Virol (2003) 0.94

Characterization of hamster tumors induced by simian virus 40 small t deletion mutants as true histiocytic lymphomas. Cancer Res (1989) 0.93

Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Curr Opin Neurol (1995) 0.93

Protein phosphatase 2A and phosphatidylinositol 3-kinase regulate the activity of Sp1-responsive promoters. J Biol Chem (2000) 0.92

DNA replication of chimeric JC virus-simian virus 40 genomes. Virology (1994) 0.92

Regulation of positive-strand RNA virus replication: the emerging role of phosphorylation. Virus Res (2007) 0.91

SV40 early region oncoproteins and human cell transformation. Histol Histopathol (2003) 0.89

Overexpression of simian virus 40 small-T antigen blocks centrosome function and mitotic progression in human fibroblasts. J Virol (2001) 0.88

Altered DNA binding and replication activities of JC virus T-antigen mutants. Virology (1991) 0.87

Stability and function of JC virus large T antigen and T' proteins are altered by mutation of their phosphorylated threonine 125 residues. J Virol (2006) 0.86

Inhibition of SV40 large T antigen induced apoptosis by small T antigen. Oncogene (1999) 0.85

Transcription initiation sites of prototype and variant JC virus early and late messenger RNAs. Virology (1993) 0.84

Phosphorylation of viral RNA-dependent RNA polymerase and its role in replication of a plus-strand RNA virus. J Biol Chem (2006) 0.84

T' proteins influence JC virus biology. J Neurovirol (2003) 0.79

Articles by these authors

Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (2012) 2.92

Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol (2004) 2.20

Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann Neurol (2008) 1.82

HIV-1 associated dementia: symptoms and causes. Retrovirology (2006) 1.70

Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst (2002) 1.69

Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke (2002) 1.66

Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J Neurosci Res (2006) 1.63

Regulation of gene expression in primate polyomaviruses. J Virol (2009) 1.61

Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma. Cancer Biol Ther (2011) 1.61

Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol (2006) 1.58

Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res (2002) 1.54

Protective role of Puralpha to cisplatin. Cancer Biol Ther (2008) 1.44

Pathogenesis of progressive multifocal leukoencephalopathy--revisited. J Infect Dis (2011) 1.43

Development of a bidirectional caspase-3 expression system for the induction of apoptosis. Cancer Biol Ther (2008) 1.42

Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma. Cell Cycle (2012) 1.41

Role of Purα in the cellular response to ultraviolet-C radiation. Cell Cycle (2010) 1.41

Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle (2009) 1.39

IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci U S A (2010) 1.36

JC virus-induced changes in cellular gene expression in primary human astrocytes. J Virol (2003) 1.36

Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol (2004) 1.28

BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol (2011) 1.27

CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J (2010) 1.23

Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem (2009) 1.21

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene (2002) 1.21

Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology (2004) 1.21

The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. J Cell Physiol (2005) 1.21

Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination. Mol Cell Biol (2003) 1.21

Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol (2015) 1.21

Evidence for BAG3 modulation of HIV-1 gene transcription. J Cell Physiol (2007) 1.20

Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a. J Cell Physiol (2008) 1.19

Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene (2002) 1.19

Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol (2002) 1.17

Insulin-like growth factor I receptor activity in human medulloblastomas. Clin Cancer Res (2002) 1.15

Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer (2005) 1.15

Role of JC virus agnoprotein in DNA repair. J Virol (2004) 1.14

Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome. J Virol (2004) 1.13

Progressive multifocal leukoencephalopathy: clinical and molecular aspects. Rev Med Virol (2011) 1.13

Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system. J Cell Biochem (2010) 1.13

Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. J Neurosci (2006) 1.12

Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J Virol (2006) 1.12

Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity. Cancer Biol Ther (2009) 1.10

Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol (2010) 1.10

Alterations of DNA damage repair pathways resulting from JCV infection. Virology (2007) 1.10

The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. PLoS Pathog (2013) 1.10

Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation. Lab Invest (2008) 1.10

Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity. J Neuropathol Exp Neurol (2008) 1.09

Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology (2006) 1.09

T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J Cell Physiol (2006) 1.08

Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur J Cancer (2005) 1.08

Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int J Cancer (2008) 1.08

Effect of HIV-1 Vpr on cell cycle regulators. DNA Cell Biol (2004) 1.08

Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging (2006) 1.08

Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes. J Neuroimmunol (2005) 1.07

Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. J Biol Chem (2004) 1.07

Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection. J Virol (2004) 1.06

Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties. J Virol (2004) 1.05

JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis. J Virol (2007) 1.05

Modulation of JC virus transcription by C/EBPbeta. Virus Res (2009) 1.05

Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology (2008) 1.05

Human polyomaviruses and brain tumors. Brain Res Brain Res Rev (2005) 1.04

Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging (2008) 1.03

Interaction between JCV large T-antigen and beta-catenin. Oncogene (2004) 1.03

Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein. J Virol (2002) 1.03

Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Virology (2003) 1.03

Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy. Am J Pathol (2007) 1.02

Cdk9 phosphorylates p53 on serine 392 independently of CKII. J Cell Physiol (2006) 1.02

Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation. J Cell Physiol (2008) 1.02

Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins. J Cell Sci (2008) 1.02

JCV T-antigen interacts with the neurofibromatosis type 2 gene product in a transgenic mouse model of malignant peripheral nerve sheath tumors. Oncogene (2004) 1.01

HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS One (2013) 1.01

Evidence for phosphatase activity of p27SJ and its impact on the cell cycle. J Cell Biochem (2009) 1.01

Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region. Anticancer Res (2007) 1.01

Viruses and cancer: lessons from the human polyomavirus, JCV. Oncogene (2003) 1.00

Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem (2002) 1.00

Regulation of human neurotropic JC virus replication by alternative splicing factor SF2/ASF in glial cells. PLoS One (2011) 0.99

Nuclear factor kappa B signaling initiates early differentiation of neural stem cells. Stem Cells (2012) 0.99

Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis (2004) 0.99

BAG3: a new player in the heart failure paradigm. Heart Fail Rev (2015) 0.98

MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion. J Neuroimmunol (2006) 0.98

Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes. J Cell Physiol (2006) 0.98

Potential mechanisms of the human polyomavirus JC in neural oncogenesis. J Neuropathol Exp Neurol (2008) 0.98

An overview: Human polyomavirus JC virus and its associated disorders. J Neurovirol (2003) 0.98

Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J Virol (2003) 0.98

Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content. Virol J (2011) 0.97

Evidence for involvement of transforming growth factor beta1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progressive multifocal leukoencephalopathy. Arch Pathol Lab Med (2004) 0.96

p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. Mol Cell Biol (2005) 0.96

Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. Biomed Pharmacother (2003) 0.96

Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen. J Virol (2003) 0.96

Insulin-like growth factor I receptor signaling system in JC virus T antigen-induced primitive neuroectodermal tumors--medulloblastomas. J Neurovirol (2002) 0.96